Literature DB >> 5508157

[Non-indicated insulin treatment].

B Knick, O Wendt, P Netter, M L Konder, B Friedel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5508157     DOI： 10.1007/bf01556796

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN： 0001-5563


× No keyword cloud information.
  10 in total

1.  A SURVEY OF CURRENT THERAPY OF DIABETES MELLITUS.

Authors:  S B BEASER
Journal:  Diabetes       Date:  1964 Sep-Oct       Impact factor: 9.461

2.  "Secondary failures" in the treatment of diabetes mellitus with tolbutamide and with phenformin.

Authors:  L P KRALL; R F BRADLEY
Journal:  Diabetes       Date:  1962       Impact factor: 9.461

3.  [ON THE CLINICAL ADJUSTABILITY OF VARIOUS FORMS OF DIABETES IN DELAYED-ACTION INSULIN THERAPY, COMBINED AND EXCLUSIVELY ORAL THERAPY WITH SULFONYLUREA DERIVATIVES AND BIGUANIDES].

Authors:  B KNICK; F FOLKERT
Journal:  Munch Med Wochenschr       Date:  1965-01-08

4.  The combined use of insulin, tolbutamide and biguanides in the treatment of diabetes mellitus. Clinical significance and experimental findings.

Authors:  W CREUTZFELDT; H D SOELING; Z ZARDAY
Journal:  Metabolism       Date:  1963-04       Impact factor: 8.694

5.  Tolbutamide-phenformin in ketoacidosis-resistant patients.

Authors:  R H UNGER; L L MADISON; N W CARTER
Journal:  JAMA       Date:  1960-12-24       Impact factor: 56.272

6.  [Clinical experiences with hypoglycemic biguanide].

Authors:  H MEHNERT; W SEITZ
Journal:  Munch Med Wochenschr       Date:  1958-07-11

7.  The uses of biguanides in diabetes mellitus.

Authors:  H Keen; R J Jarrett
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401

8.  [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors:  H Mehnert; E Karg
Journal:  Dtsch Med Wochenschr       Date:  1969-04-18       Impact factor: 0.628

9.  Role of phenformin (DBI) as an adjuvant in oral antidiabetic therapy.

Authors:  J I Goodman
Journal:  Metabolism       Date:  1965-11       Impact factor: 8.694

10.  [HB 419 (glibenclamide) and possibilities of its combinations in the treatment of diabetes mellitus].

Authors:  F W Stratmann
Journal:  Dtsch Med J       Date:  1970-01
  10 in total
  1 in total

1.  Diabetes mellitus. Distinguishing between patients receiving insulin and those requiring insulin therapy.

Authors:  R J Mahler
Journal:  West J Med       Date:  1974-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.